
A study, led by Richard Cheng under the supervision of Axel Guenther, published in Biofabrication revealed that the 3D printer completed successful in-vivo trials on full-thickness wounds, according to a report in University of Toronto Engineering News. The researchers see the printer as an alternative to the current standard of care, which is skin grafting.
Get the full story at our sister site, Drug Delivery Business News.